Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan.
作者信息
Makuuchi Masatoshi, Kokudo Norihiro
出版信息
World J Gastroenterol. 2006 Feb 7;12(5):828-9. doi: 10.3748/wjg.v12.i5.828.
Abstract
摘要
相似文献
1
Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan.
World J Gastroenterol. 2006 Feb 7;12(5):828-9. doi: 10.3748/wjg.v12.i5.828.
2
Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians.
Gut. 2007 Jul;56(7):1020-1. doi: 10.1136/gut.2007.119362.
3
Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.
J Gastroenterol. 2009;44 Suppl 19:119-21. doi: 10.1007/s00535-008-2244-z. Epub 2009 Jan 16.
4
Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
Oncology. 2014;87 Suppl 1:78-81. doi: 10.1159/000368149. Epub 2014 Nov 22.
5
Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
Oncology. 2007;72 Suppl 1:2-15. doi: 10.1159/000111702. Epub 2007 Dec 13.
6
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan.
Dig Dis. 2015 Oct;33(6):765-70. doi: 10.1159/000439101. Epub 2015 Oct 21.
7
Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.
Drug Discov Ther. 2014 Apr;8(2):64-70. doi: 10.5582/ddt.8.64.
8
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.
9
[Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
Nihon Geka Gakkai Zasshi. 2008 Nov;109(6):343-8.
10
Challenges of Clinical Research on Hepatocellular Carcinoma.
Dig Dis. 2015 Oct;33(6):780-90. doi: 10.1159/000439103. Epub 2015 Oct 21.
引用本文的文献
1
Predictive value of intra-hepatectomy ICGR15 of the remnant liver for post-hepatectomy liver failure in hemi-hepatectomy: a prospective study.
BMC Cancer. 2025 May 16;25(1):881. doi: 10.1186/s12885-025-14296-5.
2
Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma.
Oncol Lett. 2024 Apr 25;27(6):283. doi: 10.3892/ol.2024.14416. eCollection 2024 Jun.
3
Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy.
Clin J Gastroenterol. 2024 Jun;17(3):401-411. doi: 10.1007/s12328-024-01938-7. Epub 2024 Mar 26.
4
Unsupervised Machine Learning of MRI Radiomics Features Identifies Two Distinct Subgroups with Different Liver Function Reserve and Risks of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
Cancers (Basel). 2023 Jun 15;15(12):3197. doi: 10.3390/cancers15123197.
5
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison.
Clin Mol Hepatol. 2023 Apr;29(2):252-262. doi: 10.3350/cmh.2023.0099. Epub 2023 Mar 10.
6
Hepatolithiasis Classification Based on Anatomical Hepatectomy.
J Gastrointest Surg. 2023 May;27(5):914-925. doi: 10.1007/s11605-022-05572-x. Epub 2023 Jan 17.
7
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study.
Oncol Lett. 2022 Aug 31;24(4):367. doi: 10.3892/ol.2022.13487. eCollection 2022 Oct.
8
Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma.
World J Hepatol. 2022 Jul 27;14(7):1480-1494. doi: 10.4254/wjh.v14.i7.1480.
9
Potential of PALBI-T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease.
JGH Open. 2022 Jan 5;6(1):36-43. doi: 10.1002/jgh3.12705. eCollection 2022 Jan.
10
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19.
本文引用的文献
1
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.
Gut. 2003 May;52 Suppl 3(Suppl 3):iii1-8. doi: 10.1136/gut.52.suppl_3.iii1.
2
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
N Engl J Med. 1996 Mar 14;334(11):693-9. doi: 10.1056/NEJM199603143341104.
Zotero 插件